LUNG Q1 2025 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$75M

Q1 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$23M+19.5% YoY

Gross Profit

$16M72.5% margin

Operating Income

-$15M-64.6% margin

Net Income

-$14M-64.1% margin

EPS (Diluted)

$-0.36

QoQ Revenue Growth

-5.2%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$14M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$151M

Total Liabilities

$73M

Stockholders' Equity

$78M

Cash & Equivalents

$75M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23M	$19M	+19.5%
Gross Profit	$16M	$14M	+16.9%
Operating Income	-$15M	-$15M	-0.2%
Net Income	-$14M	-$14M	-5.1%

Geographic Segments

UNITED STATES

$14M63%

EMEA

$5M24%

Asia Pacific

$3M12%

Other International Geographical Areas

$38,0000%